Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Nov'25
Nov'24
Nov'23
Nov'22
Nov'21
Nov'20
Nov'19
Net Sales
83.98
54.55
76.99
38.63
29.75
17.82
31.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
83.98
54.55
76.99
38.63
29.75
17.82
31.11
Raw Material Cost
18.86
16.43
13.65
10.81
6.08
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
42.63
38.83
36.78
32.54
27.91
16.31
8.33
Other Expenses
30.82
21.23
18.16
17.91
11.36
6.43
4.27
Total Expenditure (Excl Depreciation)
369.65
267.58
232.05
222.49
147.64
80.62
51.00
Operating Profit (PBDIT) excl Other Income
-285.7
-213
-155.1
-183.9
-117.89999999999999
-62.800000000000004
-19.9
Other Income
21.97
19.73
11.12
3.51
0.82
1.21
0.78
Operating Profit (PBDIT)
-244.84
-176.87
-130.29
-169.55
-110.98
-61.60
-19.11
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
65.12
38.12
63.33
27.82
23.67
0.00
0.00
Depreciation
18.86
16.43
13.65
10.81
6.08
2.18
2.35
Profit Before Tax
-263.70
-193.30
-143.95
-180.36
-117.06
-63.78
-21.46
Tax
0.76
0.27
0.00
0.00
0.13
-20.54
0.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-264.46
-193.57
-143.95
-180.36
-117.19
-43.24
-21.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-264.46
-193.57
-143.95
-180.36
-117.19
-43.24
-21.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-264.46
-193.57
-143.95
-180.36
-117.19
-43.24
-21.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
538.75
526.99
200.49
303.70
342.30
290.27
-57.71
Earnings per share (EPS)
-3.05
-2.88
-2.65
-3.71
-2.73
-2.76
-0.56
Diluted Earnings per share
-3.05
-2.88
-2.65
-3.71
-2.73
-2.76
-0.56
Operating Profit Margin (Excl OI)
-340.16%
-390.52%
-201.41%
-476.01%
-396.26%
-364.66%
-71.46%
Gross Profit Margin
-291.55%
-324.24%
-169.24%
-438.95%
-373.05%
-345.66%
-61.4%
PAT Margin
-314.9%
-354.85%
-186.98%
-466.93%
-393.93%
-242.66%
-69.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Nov 2025 is 54.13% vs -29.22% in Nov 2024
Consolidate Net Profit
YoY Growth in year ended Nov 2025 is -36.62% vs -34.54% in Nov 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Nov 2025 is -35.71% vs -39.04% in Nov 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Nov 2025 has improved from Nov 2024
Compare Annual Results Of Nurix Therapeutics, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
83.98
0.00
83.98
Other Operating Income
0.00
0.00
0.00
Total Operating income
83.98
0.00
83.98
Raw Material Cost
18.86
0.31
18.55
5,983.87%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
42.63
53.94
-11.31
-20.97%
Other Expenses
30.82
18.74
12.08
64.46%
Total Expenditure (Excl Depreciation)
369.65
241.65
128.00
52.97%
Operating Profit (PBDIT) excl Other Income
-285.67
-241.65
-44.02
-18.22%
Other Income
21.97
21.77
0.20
0.92%
Operating Profit (PBDIT)
-244.84
-219.57
-25.27
-11.51%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
65.12
-0.31
65.43
21,106.45%
Depreciation
18.86
0.31
18.55
5,983.87%
Profit Before Tax
-263.70
-219.88
-43.82
-19.93%
Tax
0.76
0.00
0.76
Provisions and contingencies
0
0
0.00
Profit After Tax
-264.46
-219.88
-44.58
-20.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-264.46
-219.88
-44.58
-20.27%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-264.46
-219.88
-44.58
-20.27%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
538.75
408.73
130.02
31.81%
Earnings per share (EPS)
-3.05
-3.72
0.67
18.01%
Diluted Earnings per share
-3.05
-3.72
0.67
18.01%
Operating Profit Margin (Excl OI)
-340.16%
0.00%
0.00
-340.16%
Gross Profit Margin
-291.55%
0.00%
0.00
-291.55%
PAT Margin
-314.90%
0.00%
0.00
-314.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 8.40 Million
in Nov 2025Figures in Million
YoY Growth in year ended Nov 2025 is 54.13% vs -29.22% in Nov 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -26.45 Million
in Nov 2025Figures in Million
YoY Growth in year ended Nov 2025 is -36.62% vs -34.54% in Nov 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -26.68 Million
in Nov 2025Figures in Million
YoY Growth in year ended Nov 2025 is -35.71% vs -39.04% in Nov 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -340.16%
in Nov 2025Figures in %
YoY Growth in year ended Nov 2025 has improved from Nov 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
